Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated? (Q41043436)

26 September 2017

1 reference

title

Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated? (English)

1 reference

26 September 2017

1 reference

coronary artery disease

1 reference

5

Califf RM

1 reference

26 September 2017

2

Peterson ED

1 reference

26 September 2017

Fetters JK

1

1 reference

26 September 2017

Shaw LJ

series ordinal

3

1 reference

26 September 2017

Newby LK

series ordinal

4

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

26 September 2017

published in

American Heart Journal

1 reference

26 September 2017

volume

131

1 reference

26 September 2017

issue

4

1 reference

26 September 2017

page(s)

796-813

1 reference

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Epidemiology of coronary heart disease: the Framingham study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Estimating the likelihood of significant coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Coronary heart disease in residents of Rochester, Minnesota. V. Prognosis of patients with coronary heart disease based on initial manifestation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Coronary artery disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Pathophysiological dilemma of syndrome X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Mechanisms of angina pectoris in syndrome X.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Acute myocardial infarction: sex-related differences in prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Risk factors and in-hospital course of first episode of myocardial infarction or acute coronary insufficiency in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Acute myocardial infarction in women: influence of gender on mortality and prognostic variables.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Causes of higher in-hospital mortality in women than in men after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Coronary heart disease in women: a 'new' problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Coronary heart disease in women: special considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Relative and Absolute Excess Risks of Coronary Heart Disease among Women Who Smoke Cigarettes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Smoking and mortality among older men and women in three communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

An updated coronary risk profile. A statement for health professionals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

High-density lipoproteins: epidemiologic profile and risks of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Mortality among diabetics in a national sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Determinants of incident non-insulin-dependent diabetes mellitus among blacks and whites in a national sample. The NHANES I Epidemiologic Follow-up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

High mortality in obese women diabetics with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Prevalence and mortality of acute myocardial infarction in patients with diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Cardiovascular disease risk factors and mortality among black women and white women aged 40-64 years in Evans County, Georgia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Sex differences in cardiac adaptation to isolated systolic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

How soon after quitting smoking does risk of heart attack decline?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Decline in the risk of myocardial infarction among women who stop smoking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Trends in cigarette smoking in the United States. The changing influence of gender and race

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Predictors of smoking cessation: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

A description of cigarette smoking cessation and resumption in the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

A prospective study of obesity and risk of coronary heart disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Oral contraceptives, fibrinogen and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Risks and mechanisms of cardiovascular events in users of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Acute vascular effects of estrogen in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Menopause and risk factors for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Menopause and coronary heart disease. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The impact of female hormone usage on the lipid profile. The Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Oral contraceptives and nonfatal myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Oral-contraceptive use in relation to myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Hormone therapy to prevent disease and prolong life in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Estimating the likelihood of severe coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Association of risk factor variables and coronary artery disease documented with angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Risk factors and angiographic coronary artery disease: a report from the coronary artery surgery study (CASS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Prognosis of 1000 young women studied by coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Differences in electrocardiographic response to exercise of women and men: a non-Bayesian factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Factors affecting sensitivity and specificity of exercise electrocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Inability of exercise-induced R wave changes to predict coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Influence of R wave analysis upon diagnostic accuracy of exercise testing in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Noninvasive diagnostic test choices for the evaluation of coronary artery disease in women: a multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Diagnostic value of exercise electrocardiography and thallium myocardial scintigraphy in patients without previous myocardial infarction: a Bayesian approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

State-of-the-art myocardial perfusion imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Exercise echocardiographic detection of coronary artery disease in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Accuracy of diagnosis of coronary artery disease by radionuclide management of left ventricular function during rest and exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Noninvasive identification of severe coronary artery disease using exercise radionuclide angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Prognostic value of dipyridamole thallium-201 imaging in elderly patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Comparison of accuracy for detecting coronary artery disease and side-effect profile of dipyridamole thallium-201 myocardial perfusion imaging in women versus men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients. An analysis of clinical and scintigraphic variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The exclusion of the elderly and women from clinical trials in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Gender differences in the treatment of patients with acute myocardial infarction. A multihospital, community-based perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Underutilization of thrombolytic therapy in eligible women with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The effect of diltiazem on mortality and reinfarction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Politically correct clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Restenosis after coronary angioplasty: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Restenosis after transluminal coronary angioplasty: a risk factor analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Comparison of major complication rates with new atherectomy devices for percutaneous coronary intervention in women versus men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Increased mortality of women in coronary artery bypass surgery: evidence for referral bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Coronary artery surgery in women compared with men: analyses of risks and long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Coronary artery bypass grafting in women. A ten-year perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Gender differences in mortality rates for coronary artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Myocardial Revascularization in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Comparison of the long-term, postsurgical survival of women and men in the Coronary Artery Surgery Study (CASS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Exercise as a coronary protective factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

An overview of randomized trials of rehabilitation with exercise after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Comparison of the clinical profile and outcome of women and men in cardiac rehabilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Referral patterns and exercise response in the rehabilitation of female coronary patients aged greater than or equal to 62 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Differences in the use of procedures between women and men hospitalized for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Sex bias in considering coronary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Absence of sex bias in the referral of patients for cardiac catheterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

Nutrition and the occurrence and prevention of cardiovascular disease in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990289-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(96)90289-6

1 reference

26 September 2017

1 reference